Manuel Maia

1.2K posts

Manuel Maia banner
Manuel Maia

Manuel Maia

@manuelmaiamd

Medical Oncologist Focused on GU Oncology at Porto Dias Hospital, Belém-PA, Brazil. Former Fellow of GU Oncology at City Of Hope, CA

Belém, Brazil شامل ہوئے Haziran 2016
389 فالونگ949 فالوورز
Manuel Maia
Manuel Maia@manuelmaiamd·
@gleisi Melhor é enriquecer vocês, não é?
Rio de Janeiro, Brazil 🇧🇷 Português
0
0
0
0
Gleisi Hoffmann
Gleisi Hoffmann@gleisi·
Passada a eleição volta a sangria na Petrobras. Estão preparando a distribuição de $ 50 bilhões em dividendos. Não concordamos com essa política que retira da empresa sua capacidade de investimento e só enriquece acionistas. A Petrobras tem de servir ao povo brasileiro
Brasília, Brazil 🇧🇷 Português
11.7K
4.5K
30K
0
Manuel Maia
Manuel Maia@manuelmaiamd·
2nd International Uro-Oncology Symposium and we are truly honored to have dr @koshkin85 on board this year discussing psma-targeted therapies in PCa.
Manuel Maia tweet media
Belém, Brazil 🇧🇷 English
0
0
6
0
Jun Gong
Jun Gong@jgong15·
Incredibly fortunate and honored to receive the @ConquerCancerFd #CDA and deeply grateful to my mentors, wouldn’t be here without their guidance @CedarsSinai @CSCancerCare congrats to all 2022 @ASCO Awardees!
Conquer Cancer, the ASCO Foundation@ConquerCancerFd

#ASCO22 is less than two weeks away, and we’ll be awarding more than $12 million in support to these and other incredible cancer researchers! Special thanks to Conquer Cancer donors, and congratulations to the recipients of our 2022 Grants & Awards! #cancerresearch #oncology

Los Angeles, CA 🇺🇸 English
14
8
57
0
Manuel Maia ری ٹویٹ کیا
Manuel Maia ری ٹویٹ کیا
Tom Powles
Tom Powles@tompowles1·
Many muscle invasive bladder cancer patients are cured with surgery. These patents don’t need adjuvant therapy. CtDNA identifies patients at risk of relapse. ctDNA+ves also appear to benefit from adjuvant atezo. Imvigor011 (below) validates this and has screened its first patient
Tom Powles tweet media
English
10
76
194
0
Manuel Maia ری ٹویٹ کیا
GU Cancer Research Program @HuntsmanCancer
Amazing to see mCRPC #ProstateCancer progressing on abiraterone 👉respond to high dose testosterone (T) inj👉 huge potential when biomarkers to predict response to T available. Congrats to our faculty @neerajaiims , 3rd author on this landmark study in JCO @JCO_ASCO @NeliMUlrich
GU Cancer Research Program @HuntsmanCancer tweet mediaGU Cancer Research Program @HuntsmanCancer tweet mediaGU Cancer Research Program @HuntsmanCancer tweet media
Neeraj Agarwal, MD, FASCO@neerajaiims

Just in @JCO_ASCO 👉 Bipolar androgen Rx/BAT was as efficacious as enzalutamide after abiraterone in mCRPC #ProstateCancer . Fantastic collaboration including @huntsmancancer Great outcome with enza after BAT 👇bit.ly/3dF4hq7 @EAntonarakis @sonpavde @OncoAlert @urotoday

English
2
19
32
0
Manuel Maia ری ٹویٹ کیا
Sumanta K. Pal, MD, FASCO
Sumanta K. Pal, MD, FASCO@montypal·
Thanks @PauloBergerot! Really enjoyed the discussion w @DVAraujoMD who I think could easily be a professional news broadcaster! @crisbergerot @manuelmaiamd @SoaresAndrey @DrAndreFay @StenioZequi
Paulo G Bergerot@PauloBergerot

Outstanding @onconews interview w @montypal conducted by @DVAraujoMD about @swog 1500 / #Papmet results & #GU21 highlights. 👉onconews.com.br/site/component… @crisbergerot @manuelmaiamd ;-) @CityofHope_GU

English
3
4
14
0